Balyasny Asset Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Balyasny Asset Management’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-113,050	Closed	-$3.05M	–	3368
2022 Q4	$3.05M	Buy	+113,050	New	+$2.97M	0.01%	1233
2022 Q3	–	Sell	-417,496	Closed	-$5.19M	–	3405
2022 Q2	$5.19M	Buy	417,496 +105,148	+34%	+$1.16M	0.02%	919
2022 Q1	$4.16M	Buy	312,348 +109,777	+54%	+$1.47M	0.01%	1024
2021 Q4	$3.15M	Buy	+202,571	New	+$3.87M	0.01%	1016

Other funds holding MYOV

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Balyasny Asset Management's MYOV Position: Q1 2023 in Review

Balyasny Asset Management sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 113,050 shares — an estimated $3.05M sold.

Balyasny Asset Management first reported a position in MYOV in Q4 2021 and held it in 4 quarters. The position peaked at $5.19M in Q2 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

Balyasny Asset Management reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
Balyasny Asset Management sold 113,050 Myovant Sciences Ltd. shares in Q1 2023, an estimated $3.05M.
Balyasny Asset Management first reported a position in Myovant Sciences Ltd. in Q4 2021 and held it in 4 quarters.
Balyasny Asset Management's Myovant Sciences Ltd. position peaked at $5.19M in Q2 2022.
2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Balyasny Asset Management's 13F filing for Q1 2023, filed 15 May 2023.